A citation-based method for searching scientific literature

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Yuko Hosoe, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi. J Clin Oncol 2015
Times Cited: 606







List of co-cited articles
779 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Enhancing Chimeric Antigen Receptor T-Cell Efficacy in Solid Tumors.
Giovanni Fucà, Loic Reppel, Elisa Landoni, Barbara Savoldo, Gianpietro Dotti. Clin Cancer Res 2020
28
3

A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.
Hagen Kulbe, Probir Chakravarty, D Andrew Leinster, Kellie A Charles, Joseph Kwong, Richard G Thompson, Jermaine I Coward, Tiziana Schioppa, Stephen C Robinson, William M Gallagher,[...]. Cancer Res 2012
140
1

Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.
Marion Curtis, Hilary A Kenny, Bradley Ashcroft, Abir Mukherjee, Alyssa Johnson, Yilin Zhang, Ynes Helou, Raquel Batlle, Xiaojing Liu, Nuria Gutierrez,[...]. Cell Metab 2019
96
1

Myeloid-derived suppressor cells promote epithelial ovarian cancer cell stemness by inducing the CSF2/p-STAT3 signalling pathway.
Xiaofeng Li, Jiapo Wang, Weimin Wu, Hao Gao, Na Liu, Guangxi Zhan, Li Li, Lingfei Han, Xiaoqing Guo. FEBS J 2020
8
12

BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis.
Cécile Le Page, Alexandre Marineau, Patrick K Bonza, Kurosh Rahimi, Louis Cyr, Ingrid Labouba, Jason Madore, Nathalie Delvoye, Anne-Marie Mes-Masson, Diane M Provencher,[...]. PLoS One 2012
58
1

Synaptic release of CCL5 storage vesicles triggers CXCR4 surface expression promoting CTL migration in response to CXCL12.
Katarzyna Franciszkiewicz, Marie Boutet, Ludiane Gauthier, Isabelle Vergnon, Kelly Peeters, Olivier Duc, Benjamin Besse, Geneviève de Saint Basile, Salem Chouaib, Fathia Mami-Chouaib. J Immunol 2014
8
12

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.
Jason Chesney, Igor Puzanov, Frances Collichio, Parminder Singh, Mohammed M Milhem, John Glaspy, Omid Hamid, Merrick Ross, Philip Friedlander, Claus Garbe,[...]. J Clin Oncol 2018
277
1

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer.
Marie Christine Wulff Westergaard, Rikke Andersen, Chloé Chong, Julie Westerlin Kjeldsen, Magnus Pedersen, Christina Friese, Thomas Hasselager, Henrik Lajer, George Coukos, Michal Bassani-Sternberg,[...]. Br J Cancer 2019
27
3

Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
Chunyan Lan, Xin Huang, Suxia Lin, Huiqiang Huang, Qichun Cai, Ting Wan, Jiabin Lu, Jihong Liu. Technol Cancer Res Treat 2013
138
1

Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity.
João Manuel Santos, Camilla Heiniö, Victor Cervera-Carrascon, Dafne C A Quixabeira, Mikko Siurala, Riikka Havunen, Ralf Butzow, Sadia Zafar, Tanja de Gruijl, Heini Lassus,[...]. J Immunother Cancer 2020
16
6


Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.
C Tanchot, M Terme, H Pere, T Tran, N Benhamouda, M Strioga, C Banissi, L Galluzzi, G Kroemer, E Tartour. Cancer Microenviron 2013
77
1

Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment.
Yuko Tanizaki, Aya Kobayashi, Saori Toujima, Michihisa Shiro, Mika Mizoguchi, Yasushi Mabuchi, Shigetaka Yagi, Sawako Minami, Osamu Takikawa, Kazuhiko Ino. Cancer Sci 2014
47
2

The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels.
Elisenda Alsina-Sanchis, Agnès Figueras, Álvaro Lahiguera, August Vidal, Oriol Casanovas, Mariona Graupera, Alberto Villanueva, Francesc Viñals. Int J Cancer 2016
34
2

Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy.
Lisanne Noordam, Margaretha E H Kaijen, Koen Bezemer, Robin Cornelissen, Lex A P W M Maat, Henk C Hoogsteden, Joachim G J V Aerts, Rudi W Hendriks, Joost P J J Hegmans, Heleen Vroman. Oncoimmunology 2018
10
10

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications.
Jitka Fucikova, Lenka Palova-Jelinkova, Jirina Bartunkova, Radek Spisek. Front Immunol 2019
36
2

Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression.
Subramanyam Dasari, Yiming Fang, Anirban K Mitra. Cancers (Basel) 2018
35
2

Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors.
Dan Sha, Zhaohui Jin, Jan Budczies, Klaus Kluck, Albrecht Stenzinger, Frank A Sinicrope. Cancer Discov 2020
29
3

M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.
Michal Hensler, Lenka Kasikova, Karel Fiser, Jana Rakova, Petr Skapa, Jan Laco, Tereza Lanickova, Ladislav Pecen, Iva Truxova, Sarka Vosahlikova,[...]. J Immunother Cancer 2020
8
12


Infiltration of dendritic cells and T lymphocytes predicts favorable outcome in epithelial ovarian cancer.
Z Zhang, J Huang, C Zhang, H Yang, H Qiu, J Li, Y Liu, L Qin, L Wang, S Hao,[...]. Cancer Gene Ther 2015
18
5

Intratumoral heterogeneity in cancer progression and response to immunotherapy.
Ilio Vitale, Efrat Shema, Sherene Loi, Lorenzo Galluzzi. Nat Med 2021
33
3




Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy.
Paulette Mhawech-Fauceglia, Dan Wang, Damanzoopinder Samrao, Grace Kim, Kate Lawrenson, Teodulo Meneses, Song Liu, Annie Yessaian, Tanja Pejovic. Cancer Microenviron 2014
14
7

Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1.
Karolina Okła, Alicja Rajtak, Arkadiusz Czerwonka, Marcin Bobiński, Anna Wawruszak, Rafał Tarkowski, Wiesława Bednarek, Justyna Szumiło, Jan Kotarski. J Transl Med 2020
6
16

Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment.
Robert A Belderbos, Joachim G J V Aerts, Heleen Vroman. Mol Ther Oncolytics 2019
21
4

Dendritic Cell Vaccines in Ovarian Cancer.
Xi Zhang, Tianhui He, Yuan Li, Ling Chen, Hongyu Liu, Yu Wu, Hongyan Guo. Front Immunol 2021
5
20

Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer.
A N Coosemans, Thais Baert, Victoria D'Heygere, Roxanne Wouters, Lara DE Laet, Anais VAN Hoylandt, Gitte Thirion, Jolien Ceusters, Annouschka Laenen, Vincent Vandecaveye,[...]. Anticancer Res 2019
5
20

Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.
Claire Lhuillier, Nils-Petter Rudqvist, Takahiro Yamazaki, Tuo Zhang, Maud Charpentier, Lorenzo Galluzzi, Noah Dephoure, Cristina C Clement, Laura Santambrogio, Xi Kathy Zhou,[...]. J Clin Invest 2021
14
7

Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer.
Lifeng Li, Liping Wang, Jieyao Li, Zhirui Fan, Li Yang, Zhen Zhang, Chaoqi Zhang, Dongli Yue, Guohui Qin, Tengfei Zhang,[...]. Cancer Res 2018
107
1

Ovarian cancer cells induce peripheral mature dendritic cells to differentiate into macrophagelike cells in vitro.
Fangxue Chen, Meng Hou, Feng Ye, Weiguo Lv, Xing Xie. Int J Gynecol Cancer 2009
21
4

Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation.
Hina Mir, Gurpreet Kaur, Neeraj Kapur, Sejong Bae, James W Lillard, Shailesh Singh. Sci Rep 2019
11
9

FABP4 as a key determinant of metastatic potential of ovarian cancer.
Kshipra M Gharpure, Sunila Pradeep, Marta Sans, Rajesha Rupaimoole, Cristina Ivan, Sherry Y Wu, Emine Bayraktar, Archana S Nagaraja, Lingegowda S Mangala, Xinna Zhang,[...]. Nat Commun 2018
58
1

Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells.
Sonja Lieber, Silke Reinartz, Hartmann Raifer, Florian Finkernagel, Tobias Dreyer, Holger Bronger, Julia M Jansen, Uwe Wagner, Thomas Worzfeld, Rolf Müller,[...]. Oncoimmunology 2018
34
2

Stress responses in stromal cells and tumor homeostasis.
Ilio Vitale, Gwenola Manic, Claudia Galassi, Lorenzo Galluzzi. Pharmacol Ther 2019
11
9


Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
Cecilia S Leung, Tsz-Lun Yeung, Kay-Pong Yip, Kwong-Kwok Wong, Samuel Y Ho, Lingegowda S Mangala, Anil K Sood, Gabriel Lopez-Berestein, Jianting Sheng, Stephen Tc Wong,[...]. J Clin Invest 2018
65
1


Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine.
Monique B Nilsson, Robert R Langley, Isaiah J Fidler. Cancer Res 2005
230
1

The versatile plasmacytoid dendritic cell: Function, heterogeneity, and plasticity.
Rebecca Leylek, Juliana Idoyaga. Int Rev Cell Mol Biol 2019
13
7

Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells.
Curdin Conrad, Josh Gregorio, Yi-Hong Wang, Tomoki Ito, Stephan Meller, Shino Hanabuchi, Sonya Anderson, Neely Atkinson, Pedro T Ramirez, Yong-Jun Liu,[...]. Cancer Res 2012
171
1

The cancer-natural killer cell immunity cycle.
Nicholas D Huntington, Joseph Cursons, Jai Rautela. Nat Rev Cancer 2020
50
2

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
Akira Orimo, Piyush B Gupta, Dennis C Sgroi, Fernando Arenzana-Seisdedos, Thierry Delaunay, Rizwan Naeem, Vincent J Carey, Andrea L Richardson, Robert A Weinberg. Cell 2005
1

Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics.
Susan Olalekan, Bingqing Xie, Rebecca Back, Heather Eckart, Anindita Basu. Cell Rep 2021
2
50

Induction and transcriptional regulation of the co-inhibitory gene module in T cells.
Norio Chihara, Asaf Madi, Takaaki Kondo, Huiyuan Zhang, Nandini Acharya, Meromit Singer, Jackson Nyman, Nemanja D Marjanovic, Monika S Kowalczyk, Chao Wang,[...]. Nature 2018
153
1

Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.
Takahiro Yamazaki, Alexander Kirchmair, Ai Sato, Aitziber Buqué, Marissa Rybstein, Giulia Petroni, Norma Bloy, Francesca Finotello, Lena Stafford, Esther Navarro Manzano,[...]. Nat Immunol 2020
60
1

Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma.
Robert H I Andtbacka, Frances Collichio, Kevin J Harrington, Mark R Middleton, Gerald Downey, Katarina Ӧhrling, Howard L Kaufman. J Immunother Cancer 2019
94
1

Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.
Andras Ladanyi, Abir Mukherjee, Hilary A Kenny, Alyssa Johnson, Anirban K Mitra, Sinju Sundaresan, Kristin M Nieman, Gloria Pascual, Salvador Aznar Benitah, Anthony Montag,[...]. Oncogene 2018
147
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.